TY - CHAP
T1 - Telehealth and Pharmacological Strategies of COVID-19 Prevention
T2 - Current and Future Developments
AU - Battineni, Gopi
AU - Nittari, Giulio
AU - Pallotta, Graziano
AU - Sagaro, Getu Gamo
AU - Chintalapudi, Nalini
AU - Amenta, Francesco
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.
PY - 2022
Y1 - 2022
N2 - After the identification of SARS-CoV-2 virus in China, it has spread worldwide at a rapid pace. To control novel coronavirus disease (COVID-19), there is no particular treatments/immunizations are available yet. However, to avoid the risk of immediate spreading between infected individuals, and healthcare workers, most organizations adopting virtual media devices in order asses the symptomatic behaviour of patient and these services are well known for telehealth services. On other hand, repositioning of drugs can offer a controlling strategy, and several drugs including remdesivir, lopinavir/ritonavir, hydroxychloroquine (HCQ), and favipiravir were repurposed. The availability of an authenticated vaccine against COVID19 will be hard to produce in the coming days, therefore it is important to propose a pharmacological strategy to combat this disease. In this chapter, the authors present the investigation of controlling and preventing methods by telemedical services during a novel coronavirus outbreak. Besides, it can also report the current drug available information and future developments that need to present new strategies for developing pharmacy facilities.
AB - After the identification of SARS-CoV-2 virus in China, it has spread worldwide at a rapid pace. To control novel coronavirus disease (COVID-19), there is no particular treatments/immunizations are available yet. However, to avoid the risk of immediate spreading between infected individuals, and healthcare workers, most organizations adopting virtual media devices in order asses the symptomatic behaviour of patient and these services are well known for telehealth services. On other hand, repositioning of drugs can offer a controlling strategy, and several drugs including remdesivir, lopinavir/ritonavir, hydroxychloroquine (HCQ), and favipiravir were repurposed. The availability of an authenticated vaccine against COVID19 will be hard to produce in the coming days, therefore it is important to propose a pharmacological strategy to combat this disease. In this chapter, the authors present the investigation of controlling and preventing methods by telemedical services during a novel coronavirus outbreak. Besides, it can also report the current drug available information and future developments that need to present new strategies for developing pharmacy facilities.
KW - COVID-19
KW - Drug development
KW - Pharmacy services
KW - Tele pharmaceutical services
KW - Telehealth
UR - https://www.scopus.com/pages/publications/85118805357
U2 - 10.1007/978-3-030-72834-2_26
DO - 10.1007/978-3-030-72834-2_26
M3 - Chapter
AN - SCOPUS:85118805357
T3 - Studies in Systems, Decision and Control
SP - 897
EP - 927
BT - Studies in Systems, Decision and Control
PB - Springer Science and Business Media Deutschland GmbH
ER -
